Subtype-specific differences in subcellular localization of α1- adrenoceptors: Chlorethylclonidine preferentially alkylates the accessible cell surface α1-adrenoceptors irrespective of the subtype

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 764-770

  Hirasawa, Akira ^a   Sugawara, Tatsuo ^a   Awaji, Takeo ^a   Tsumaya, Keiko ^b   Ito, Hiroshi ^b   Tsujimoto, Gozoh ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IODINE 125; PHENTOLAMINE; PRAZOSIN; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0030864213     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.764     Document Type: Article

References (35)

1. Nichols, J. A., and J. R. R. Ruffolo. Functions mediated by α-adrenoceptors, in α-adrenoceptors: molecular biology, biochemistry, and pharmacology, in Progress in Basic and Molecular Pharmacology (J. R. R. Ruffolo, ed.). Karger, Basel, 115-179 (1991).
2. Hoffman, B. B., and R. J. Lefkowitz. Cathecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, eds.). McGraw-Hill, New York, 199-248 (1996).
3. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J. Biol. Chem. 268:15374-15380 (1993).
4. 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 34:117-133 (1994).
5. McGrath, J. C. Evidence for more than one type of post-junctional α-adrenoceptor. Biochem. Pharmacol. 31:467-484 (1982).
6. 3H]prazosin binding. Mol. Pharmacol. 29:321-330 (1986).
7. 2+ in smooth muscle. Nature (Lond.). 329:333-335 (1987).
8. McGrath, J., and V. Wilson. α-Adrenoceptor subclassification by classical and response-related methods: same question, different answers. Trends. Pharmacol. Sci. 9:162-165 (1988).
9. 2+ influx. Mol. Pharmacol. 36:166-176 (1989).
10. 2+ signalling mechanism and plays a different physiological role. Mol. Pharmacol. 38:725-736 (1990).
11. 1-adrenergic receptor subtypes linked to iodide efflux in rat FRTL cells. J. Endocrinol. 124:433-441 (1990).
12. 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA 85:7159-7163 (1988).
13. 1-adrenergic receptor subtype. J. Biol. Chem. 265:8183-8189 (1990).
14. 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J. Biol. Chem. 266: 6365-6369 (1991).
15. Perez, D. M., M. T. Piascik, and R. M. Graham. Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40:876-883 (1991).
16. 1C-adrenergic receptor. Biochem. Biophys. Res. Commun. 195:902-909 (1993).
17. 1C-adrenoceptor splice variants. FEBS Lett. 363:256-260 (1995).
18. 1A subtype. Mol. Pharmacol. 46:823-831 (1994).
19. 1A subtype. Mol. Pharmacol. 46:414-422 (1994).
20. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47:267-270 (1995).
21. 1-adrenoceptor subtypes mediate contraction in rabbit aorta and urethra. Eur. J. Pharmacol. 287:153-161 (1995).
22. 1-adrenoceptor subtypes. Br. J. Pharmacol. 117:703-711 (1996).
23. 1-adrenoceptor subtypes in canine aorta, using alkylating agents. Can. J. Physiol. Pharmacol. 72:97-103 (1994).
24. 1-adrenoceptor subtypes. FEBS Lett. 386:141-148 (1996).
25. 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur. J. Pharmacol. 288:201-207 (1995).
26. 1B-adrenergic receptor. J. Biol. Chem. 269:22887-22893 (1994).
27. 1-adrenoceptors and native tissues. Mol. Pharmacol. 48:250-258 (1995).
28. 1b-Adrenoceptor-mediated calcium oscillation is specific for the S phase in cell cycle and dependent on the extracellular calcium. Biochem. Biophys. Res. Commun. 224:80-86 (1996).
29. 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol. Pharmacol. 47:977-985 (1995).
30. von Zastrow, M., R. Link, D. Daunt, G. Barsh, and B. Kobilka. Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J. Biol. Chem. 268:763-766 (1993).
31. 2A adrenergic receptors achieve basolateral localization. J. Biol. Chem. 271:995-1002 (1996).
32. 1-adrenoceptor subtypes in the contraction of rabbit aorta. Br. J. Clin. Pharmacol. 30(Suppl. 1):121S-124S (1990).
33. Kurose, H., and R. J. Lefkowitz. Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes. J. Biol. Chem. 269:10093-9 (1994).
34. Maisel, A. S., H. J. Motulsky, and P. A. Insel. Externalization of beta-adrenergic receptors promoted by myocardial ischemia. Science (Washington D. C.) 230:183-6 (1985).
35. Maisel, A. S., H. J. Motulsky, and P. A. Insel. Propranolol treatment externalizes beta-adrenergic receptors in guinea pig myocardium and prevents further externalization by ischemia. Circ. Res. 60:108-12 (1987).